• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性亚临床甲状腺功能亢进患者的骨矿物质密度:这种甲状腺状态是骨质疏松症的危险因素吗?

Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?

作者信息

Földes J, Tarján G, Szathmari M, Varga F, Krasznai I, Horvath C

机构信息

First Department of Medicine, Semmelweis University, Budapest, Hungary.

出版信息

Clin Endocrinol (Oxf). 1993 Nov;39(5):521-7. doi: 10.1111/j.1365-2265.1993.tb02403.x.

DOI:10.1111/j.1365-2265.1993.tb02403.x
PMID:8252739
Abstract

OBJECTIVE

The aim of the present study was to elucidate whether endogenous subclinical hyperthyroidism due to a solitary autonomously functioning thyroid nodule affects bone metabolism and is a risk factor for osteoporosis.

DESIGN

In a cross-sectional study measurements of bone mineral density were performed in premenopausal and post-menopausal women. Patients were categorized into non-toxic nodular goitre (n = 32), subclinical hyperthyroid (n = 37) and toxic solitary autonomous thyroid nodule (n = 22) subgroups and the results were compared with those of sex and age-matched control reference population (n = 68).

MEASUREMENTS

Lumbar spine and femoral neck bone mineral densities were measured by dual energy X-ray absorptiometry. Single-photon absorptiometry was applied to the measurement of bone mineral content in the midshaft of the radius.

RESULTS

In the non-toxic nodular goitre group, bone densities for all the scanned sites did not differ from the sex and age-matched reference population. At the L2-4 scanning site a significant decrease in the bone mineral density could be observed only in the toxic nodular goitre group and this decrease was more marked in the postmenopausal (P < 0.001) than in the premenopausal females (P < 0.05). At the femoral neck and midshaft radius the mean densitometric values were slightly, but significantly, lower only in the post-menopausal subclinical hyperthyroid group compared with the reference population (P < 0.01). The bone mineral density of the femoral neck, as well as the bone mineral content of the midshaft radius, was significantly decreased in both the premenopausal and post-menopausal patients with a toxic solitary nodule.

CONCLUSION

This study indicates that the bone mineral density of the lumbar spine, femoral neck and the midshaft of the radius are not significantly decreased in premenopausal patients with endogenous subclinical hyperthyroidism resulting from a solitary autonomously functioning thyroid nodule. Conversely, findings hint at the possibility that long-lasting endogenous subclinical hyperthyroidism may be a contributing factor to the development of osteoporosis in some post-menopausal women, mostly at sites where cortical bone preponderates.

摘要

目的

本研究旨在阐明由单个自主功能性甲状腺结节引起的内源性亚临床甲状腺功能亢进是否会影响骨代谢以及是否为骨质疏松症的危险因素。

设计

在一项横断面研究中,对绝经前和绝经后女性进行骨密度测量。患者被分为非毒性结节性甲状腺肿组(n = 32)、亚临床甲状腺功能亢进组(n = 37)和毒性单个自主甲状腺结节组(n = 22),并将结果与性别和年龄匹配的对照参考人群(n = 68)的结果进行比较。

测量

采用双能X线吸收法测量腰椎和股骨颈骨密度。应用单光子吸收法测量桡骨中段的骨矿物质含量。

结果

在非毒性结节性甲状腺肿组中,所有扫描部位的骨密度与性别和年龄匹配的参考人群无差异。在L2 - 4扫描部位,仅在毒性结节性甲状腺肿组中可观察到骨密度显著降低,且绝经后女性(P < 0.001)的降低比绝经前女性(P < 0.05)更明显。与参考人群相比,仅在绝经后亚临床甲状腺功能亢进组中,股骨颈和桡骨中段的平均骨密度值略有但显著降低(P < 0.01)。绝经前和绝经后患有毒性单个结节的患者,其股骨颈骨密度以及桡骨中段的骨矿物质含量均显著降低。

结论

本研究表明,由单个自主功能性甲状腺结节引起的内源性亚临床甲状腺功能亢进的绝经前患者,其腰椎、股骨颈和桡骨中段的骨密度无显著降低。相反,研究结果提示,长期的内源性亚临床甲状腺功能亢进可能是某些绝经后女性骨质疏松症发生的一个促成因素,主要发生在皮质骨占优势的部位。

相似文献

1
Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?内源性亚临床甲状腺功能亢进患者的骨矿物质密度:这种甲状腺状态是骨质疏松症的危险因素吗?
Clin Endocrinol (Oxf). 1993 Nov;39(5):521-7. doi: 10.1111/j.1365-2265.1993.tb02403.x.
2
Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women.通过定量计算机断层扫描和单光子吸收法测定亚临床甲状腺功能亢进症患者的骨密度:绝经后女性早期骨质疏松的风险
Clin Endocrinol (Oxf). 1992 May;36(5):511-7. doi: 10.1111/j.1365-2265.1992.tb02254.x.
3
Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.甲状腺功能亢进患者及接受药物治疗的既往甲状腺功能亢进患者的骨质流失:病因及绝经的影响
Clin Endocrinol (Oxf). 1997 Sep;47(3):279-85. doi: 10.1046/j.1365-2265.1997.2261041.x.
4
Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.血清胰岛素样生长因子-I(IGF-I)和硫酸脱氢表雄酮水平降低可能是内源性亚临床甲状腺功能亢进的绝经后女性骨量减少发生的危险因素。
Eur J Endocrinol. 1997 Mar;136(3):277-81. doi: 10.1530/eje.0.1360277.
5
Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women.内源性亚临床甲状腺功能亢进对绝经前女性骨代谢和骨密度的影响。
Thyroid. 1999 Jun;9(6):539-43. doi: 10.1089/thy.1999.9.539.
6
Bone mineral density in postmenopausal women treated with L-thyroxine.接受左甲状腺素治疗的绝经后女性的骨矿物质密度
Am J Med. 1991 Mar;90(3):360-6. doi: 10.1016/0002-9343(91)90577-k.
7
A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.小剂量抑制性左甲状腺素对患有非毒性甲状腺肿的绝经前和绝经后女性的骨转换及骨密度无影响。
Horm Metab Res. 1995 Nov;27(11):503-7. doi: 10.1055/s-2007-980012.
8
Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover.内源性甲状腺功能亢进患者代谢性骨病的识别:骨转换生物标志物的作用
Calcif Tissue Int. 1997 Nov;61(5):370-6. doi: 10.1007/s002239900350.
9
Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism.通过骨定量超声检查和双能X线吸收法检测内源性亚临床甲状腺功能亢进的绝经前和绝经后女性的骨量减少情况。
Maturitas. 2004 Jul 15;48(3):299-306. doi: 10.1016/j.maturitas.2004.02.017.
10
Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.促甲状腺激素与甲状腺激素对绝经前女性骨密度和骨转换的调节作用
Endocr Regul. 2010 Apr;44(2):57-63. doi: 10.4149/endo_2010_02_57.

引用本文的文献

1
Bone Mineral Density and Bone Turnover Marker in a Subclinical Thyrotoxic State in Young Premenopausal Women.年轻绝经前女性亚临床甲状腺毒症状态下的骨密度和骨转换标志物
Cureus. 2024 Jan 20;16(1):e52610. doi: 10.7759/cureus.52610. eCollection 2024 Jan.
2
Mechanisms and Treatment Options for Hyperthyroid-Induced Osteoporosis: A Narrative Review.甲状腺功能亢进症所致骨质疏松症的发病机制与治疗选择:一篇叙述性综述
Cureus. 2023 Nov 14;15(11):e48798. doi: 10.7759/cureus.48798. eCollection 2023 Nov.
3
Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association.
甲状腺疾病患者的骨骼健康评估与管理:韩国甲状腺协会立场声明。
Endocrinol Metab (Seoul). 2023 Apr;38(2):175-189. doi: 10.3803/EnM.2023.1701. Epub 2023 Apr 27.
4
Association Between Subclinical Thyroid Dysfunction and Fracture Risk.亚临床甲状腺功能障碍与骨折风险的关系。
JAMA Netw Open. 2022 Nov 1;5(11):e2240823. doi: 10.1001/jamanetworkopen.2022.40823.
5
Thyroid Hormone Diseases and Osteoporosis.甲状腺激素疾病与骨质疏松症
J Clin Med. 2020 Apr 6;9(4):1034. doi: 10.3390/jcm9041034.
6
Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.中年韩国人群的亚临床甲状腺功能障碍、骨密度和骨质疏松症。
Osteoporos Int. 2020 Mar;31(3):547-555. doi: 10.1007/s00198-019-05205-1. Epub 2019 Nov 13.
7
Expanding the Role of Thyroid-Stimulating Hormone in Skeletal Physiology.拓展促甲状腺激素在骨骼生理学中的作用
Front Endocrinol (Lausanne). 2017 Oct 3;8:252. doi: 10.3389/fendo.2017.00252. eCollection 2017.
8
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.2015年欧洲甲状腺协会关于内源性亚临床甲状腺功能亢进症诊断和治疗的指南。
Eur Thyroid J. 2015 Sep;4(3):149-63. doi: 10.1159/000438750. Epub 2015 Aug 26.
9
Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women.内源性亚临床甲状腺功能亢进症可能不会导致绝经前女性骨质流失。
Hippokratia. 2014 Jul-Sep;18(3):240-4.
10
The influence of thyroid dysfunction on bone metabolism.甲状腺功能障碍对骨代谢的影响。
Thyroid Res. 2014 Dec 20;7(1):12. doi: 10.1186/s13044-014-0012-0. eCollection 2014.